Related Experiment Video

Updated: Sep 16, 2026

Gastric Point of Care Ultrasound in Adults: Image Acquisition and Interpretation
05:50

Gastric Point of Care Ultrasound in Adults: Image Acquisition and Interpretation

Published on: September 22, 2023

Peptic ulcer in children

T M Tsang1, H Saing, C K Yeung

  • 1Department of Surgery, University of Hong Kong, Queen Mary Hospital.

Journal of Pediatric Surgery
|July 1, 1990
PubMed

Insights

Pediatric peptic ulcers treated with H2-blockers showed varied healing times. Higher acid output correlated with longer treatment duration, and a significant recurrence rate was observed post-healing.

Area of Science:

  • Pediatric Gastroenterology
  • Gastrointestinal Surgery

Background:

  • Primary peptic ulcers are diagnosed in children.
  • Duodenal ulcers were more common than prepyloric ulcers.

Purpose of the Study:

  • To evaluate the efficacy of H2-blocker therapy in children with primary peptic ulcers.
  • To identify factors associated with treatment success and recurrence.

Main Methods:

  • Retrospective analysis of 39 children diagnosed with primary peptic ulcers between 1983 and 1989.
  • H2-blocker therapy was administered to 36 patients, with healing assessed endoscopically.
  • Basal acid output (BAO) and maximal acid output (MAO) were measured.

Main Results:

  • 33 of 36 patients completed H2-blocker therapy.
  • 49% healed within 6 weeks; 51% required multiple courses.
  • Higher BAO and MAO were significantly associated with longer healing times (P < .05 and P < .005).
  • 10 patients experienced recurrent ulcers within a mean follow-up of 1.8 years (35% 1-year recurrence rate).
  • Five patients required surgery for complications (obstruction, perforation, bleeding).

Conclusions:

  • H2-blocker therapy is effective for pediatric peptic ulcers, but some patients require prolonged treatment.
  • Elevated gastric acid output may predict slower healing.
  • Recurrence and complications necessitate long-term monitoring and management strategies.

More Related Videos

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia03:05

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia

Published on: February 16, 2024

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease I: Introduction01:25

Peptic Ulcer Disease I: Introduction

Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
Peptic Ulcer Disease III: Clinical Manifestations and Complications01:25

Peptic Ulcer Disease III: Clinical Manifestations and Complications

Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...